Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIK-RE-VAC: Chikungunya Vaccination During an Epidemic Period
NCT06928753Phase 4Recruiting
- Sponsor
- CHU de La Réunion
- Start
- Apr 2025
- Primary completion
- Jun 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of chikungunya vaccine (live), CHIKV VLP vaccine in chikungunya virus infection, sponsored by CHU de La Réunion. Started Apr 2025; status: recruiting.
02
Drugs
chikungunya vaccine (live)CHIKV VLP vaccine
03
Conditions
chikungunya virus infection
Beyond the preview
Go deeper on NCT06928753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06928753.